Walaa Nabil Abd-AlGhafar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Walaa Nabil Abd-AlGhafar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Samar Saad
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
5 shared publicationsManar M. Tolba
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt
4 shared publicationsFatma Ahmed Aly
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
3 shared publicationsRasha Abo Shabana
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt
3 shared publicationsZeinab Awad Sheribah
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
3 shared publicationsAlaa Ahmed Mostafa
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr city, Cairo, Egypt
2 shared publications
Latest Publications
- 12 October 2026
- Published by Wiley in Luminescence
- Vol. 41 (10) , e70645
Green Spectrofluorimetric Strategies for Capmatinib and Curcumin Determination
The growing convergence between precision oncology and natural‐product‐based therapeutics has fostered innovative strategies that integrate molecularly targeted anticancer agents with biologically active phytochemicals to enhance therapeutic efficacy and overcome treatment resistance. Capmatinib, a selective MET inhibitor approved for MET‐driven non‐small cell lung cancer, and curcumin, a natural polyphenol possessing antioxidant, anti‐inflammatory, and anticancer activities, represent a promising therapeutic combination. This emerging paradigm highlights the need for sensitive, sustainable, and efficient analytical platforms capable of monitoring both compounds in pharmaceutical and biological matrices. Accordingly, two new spectrofluorimetric methods were created and validated, allowing for the quantification of capmatinib and the simultaneous assay of capmatinib–curcumin combinations. The first method harnessed the unique microenvironmental properties of sodium dodecyl sulfate as a monomeric denaturant to markedly enhance the intrinsic fluorescence of capmatinib in an aqueous medium, providing a linear response over 5.0–120.0 ng/mL with a detection limit of 1.42 ng/mL. The second method exploited synchronous spectrofluorimetry (Δλ = 160 nm) to resolve overlapping fluorescence signals, enabling separation‐free quantification of capmatinib and curcumin across concentration ranges of 20.0–700.0 and 10.0–250.0 ng/mL, respectively. Both methods demonstrated excellent selectivity, accuracy, and precision according to ICH guidelines and were successfully applied to spiked human plasma samples.
- 12 October 2026
- Published by Wiley in Luminescence
- Vol. 41 (10) , e70645
Green Spectrofluorimetric Strategies for Capmatinib and Curcumin Determination
The growing convergence between precision oncology and natural‐product‐based therapeutics has fostered innovative strategies that integrate molecularly targeted anticancer agents with biologically active phytochemicals to enhance therapeutic efficacy and overcome treatment resistance. Capmatinib, a selective MET inhibitor approved for MET‐driven non‐small cell lung cancer, and curcumin, a natural polyphenol possessing antioxidant, anti‐inflammatory, and anticancer activities, represent a promising therapeutic combination. This emerging paradigm highlights the need for sensitive, sustainable, and efficient analytical platforms capable of monitoring both compounds in pharmaceutical and biological matrices. Accordingly, two new spectrofluorimetric methods were created and validated, allowing for the quantification of capmatinib and the simultaneous assay of capmatinib–curcumin combinations. The first method harnessed the unique microenvironmental properties of sodium dodecyl sulfate as a monomeric denaturant to markedly enhance the intrinsic fluorescence of capmatinib in an aqueous medium, providing a linear response over 5.0–120.0 ng/mL with a detection limit of 1.42 ng/mL. The second method exploited synchronous spectrofluorimetry (Δλ = 160 nm) to resolve overlapping fluorescence signals, enabling separation‐free quantification of capmatinib and curcumin across concentration ranges of 20.0–700.0 and 10.0–250.0 ng/mL, respectively. Both methods demonstrated excellent selectivity, accuracy, and precision according to ICH guidelines and were successfully applied to spiked human plasma samples.
- 8 August 2026
- Published by Springer Nature in Journal of Fluorescence
- Vol. 36 (9) , 5263-5279
From Golden Berry To Golden Nanoprobe: Sustainable Fluorescent Sensing of Torsemide For Doping Control in Athletes
- 8 August 2026
- Published by Springer Nature in Journal of Fluorescence
- Vol. 36 (9) , 5263-5279
From Golden Berry To Golden Nanoprobe: Sustainable Fluorescent Sensing of Torsemide For Doping Control in Athletes
- 6 July 2026
- Published by Wiley in Luminescence
- Vol. 41 (7) , e70561
Unfolding of Eco‐Innovative Multifunctional Switch‐Off Fluorescent Sensor for Omeprazole Sensing in Formulations and Environmental Samples
Investigations were applied for constructing carbon quantum dots (CDs) from a new natural source by environmentally benign techniques. Red grapes, rich in bioactive compounds, were utilized for the synthesis of S,N‐based CDs. Microwave‐assisted synthesis of CDs was applied with minimal radiation for just 6 min, which aligns with sustainability. Unlike traditional techniques that require harsh nongreen conditions, e.g., high temperature or charged molecules, this approach requires the standard household microwave temperature, which offers a readily available synthesis process with an excellent greenness level. The fabricated CDs exhibit powerful fluorescence ( λ ex / λ em of 350/445 nm) with superb water solubility. Stability and selectivity of CDs were confirmed in the presence of different ions. Crucially, the CDs were exploited for quantification of the anti‐GERD drug omeprazole (OPZ) for the first time by fluorescence quenching via static quenching. The method demonstrated an excellent regression coefficient (0.9999) and a detection limit of 0.335 μg/mL. This enabled successful OPZ estimation in dosage forms, river, and tap water with %recoveries of 99.72%–101.02%. Consequently, this sensor would be a promising avenue for quality control and environmental monitoring of micropollutants. The exceptional greenness degree was confirmed using different greenness evaluation systems: Complex‐GAPI, BAGI, AGREE, and nanomaterials assessment tool.
- 6 July 2026
- Published by Wiley in Luminescence
- Vol. 41 (7) , e70561
Unfolding of Eco‐Innovative Multifunctional Switch‐Off Fluorescent Sensor for Omeprazole Sensing in Formulations and Environmental Samples
Investigations were applied for constructing carbon quantum dots (CDs) from a new natural source by environmentally benign techniques. Red grapes, rich in bioactive compounds, were utilized for the synthesis of S,N‐based CDs. Microwave‐assisted synthesis of CDs was applied with minimal radiation for just 6 min, which aligns with sustainability. Unlike traditional techniques that require harsh nongreen conditions, e.g., high temperature or charged molecules, this approach requires the standard household microwave temperature, which offers a readily available synthesis process with an excellent greenness level. The fabricated CDs exhibit powerful fluorescence ( λ ex / λ em of 350/445 nm) with superb water solubility. Stability and selectivity of CDs were confirmed in the presence of different ions. Crucially, the CDs were exploited for quantification of the anti‐GERD drug omeprazole (OPZ) for the first time by fluorescence quenching via static quenching. The method demonstrated an excellent regression coefficient (0.9999) and a detection limit of 0.335 μg/mL. This enabled successful OPZ estimation in dosage forms, river, and tap water with %recoveries of 99.72%–101.02%. Consequently, this sensor would be a promising avenue for quality control and environmental monitoring of micropollutants. The exceptional greenness degree was confirmed using different greenness evaluation systems: Complex‐GAPI, BAGI, AGREE, and nanomaterials assessment tool.
- 3 June 2026
- Published by Wiley in Luminescence
- Vol. 41 (6) , e70524
Simultaneous Determination of Capmatinib and Resveratrol via Micellar‐Enhanced Synchronized Fluorescence Spectroscopy: Application to Human Plasma and Environmental Water Samples
A novel, eco‐friendly, and highly sensitive synchronous spectrofluorimetric method was developed and validated for the first time to simultaneously determine the synergistic chemotherapy agents, capmatinib (CMT) and resveratrol (RES). The method relies on the native fluorescence characteristics of both drugs, ensuring excellent sensitivity and selectivity without prederivatization. Simultaneous quantification was achieved at 407 nm for CMT and 306 nm for RES with a wavelength difference (∆λ) of 80 nm, using water and 1.5 mL of 1% Kolliphor as a green solvent system. Validation was performed in accordance with ICH guidelines, confirming satisfactory linearity, precision, accuracy, and selectivity. The linear concentration ranges were 50.0–1800.0 and 5.0–100.0 ng/mL for CMT and RES, with detection limits of 11.69 and 1.34 ng/mL, respectively. Owing to its high sensitivity, the developed method was successfully applied to human plasma samples, achieving excellent recovery values of 95.04%–105.54% and 94.60%–104.52% for CMT and RES, respectively, which supports its bioanalytical suitability. Moreover, the method was applied for trace analysis of both drugs in tap water and river water samples with %recoveries of 95.03%–99.14% and 94.34%–101.08% for CMT and RES, respectively. The environmental sustainability along with the operational efficiency of the proposed approach was further assessed.
- 3 June 2026
- Published by Wiley in Luminescence
- Vol. 41 (6) , e70524
Simultaneous Determination of Capmatinib and Resveratrol via Micellar‐Enhanced Synchronized Fluorescence Spectroscopy: Application to Human Plasma and Environmental Water Samples
A novel, eco‐friendly, and highly sensitive synchronous spectrofluorimetric method was developed and validated for the first time to simultaneously determine the synergistic chemotherapy agents, capmatinib (CMT) and resveratrol (RES). The method relies on the native fluorescence characteristics of both drugs, ensuring excellent sensitivity and selectivity without prederivatization. Simultaneous quantification was achieved at 407 nm for CMT and 306 nm for RES with a wavelength difference (∆λ) of 80 nm, using water and 1.5 mL of 1% Kolliphor as a green solvent system. Validation was performed in accordance with ICH guidelines, confirming satisfactory linearity, precision, accuracy, and selectivity. The linear concentration ranges were 50.0–1800.0 and 5.0–100.0 ng/mL for CMT and RES, with detection limits of 11.69 and 1.34 ng/mL, respectively. Owing to its high sensitivity, the developed method was successfully applied to human plasma samples, achieving excellent recovery values of 95.04%–105.54% and 94.60%–104.52% for CMT and RES, respectively, which supports its bioanalytical suitability. Moreover, the method was applied for trace analysis of both drugs in tap water and river water samples with %recoveries of 95.03%–99.14% and 94.34%–101.08% for CMT and RES, respectively. The environmental sustainability along with the operational efficiency of the proposed approach was further assessed.
- 17 March 2024
- Published by Wiley in Luminescence
- Vol. 39 (3) , e4696
Environmentally benign first derivative synchronous spectrofluorimetry for the analysis of two binary mixtures containing duloxetine with avanafil or tadalafil in spiked plasma samples
Antidepressants can cause sexual dysfunction side effects, necessitating the co‐administration of phosphodiesterase type 5 inhibitors. The simultaneous determination of these drugs in biological fluids is critical for therapeutic drug monitoring. For the first time, two binary mixtures containing duloxetine with either avanafil or tadalafil were estimated utilizing simple green spectrofluorimetric methods without the need for a previous separation step. The study was based on first derivative synchronous spectrofluorimetry in ethanol using a change in wavelength difference (∆λ) of 20 and 25 nm for the first and second combinations, respectively. Duloxetine and avanafil were estimated at 297.7 and 331 nm in their binary mixture, while duloxetine and tadalafil were determined at 290.3 and 297.7 nm, respectively. The linearity was achieved over the ranges of 0.1–1.5 μg mL−1 for both duloxetine and avanafil and 0.01–0.40 μg mL−1 for tadalafil, with limits of detection of 0.013, 0.022, and 0.004 μg mL−1 for duloxetine, avanafil, and tadalafil, respectively. Successful application of the developed approaches was accomplished for the estimation of the two mixtures in dosage forms as well as human plasma with excellent percentage recoveries (96–103.75% in plasma), which supports their suitability for use in quality control laboratories and pharmacokinetic studies. Moreover, the adopted approaches' greenness was evidenced by applying three tools.
- 17 March 2024
- Published by Wiley in Luminescence
- Vol. 39 (3) , e4696
Environmentally benign first derivative synchronous spectrofluorimetry for the analysis of two binary mixtures containing duloxetine with avanafil or tadalafil in spiked plasma samples
Antidepressants can cause sexual dysfunction side effects, necessitating the co‐administration of phosphodiesterase type 5 inhibitors. The simultaneous determination of these drugs in biological fluids is critical for therapeutic drug monitoring. For the first time, two binary mixtures containing duloxetine with either avanafil or tadalafil were estimated utilizing simple green spectrofluorimetric methods without the need for a previous separation step. The study was based on first derivative synchronous spectrofluorimetry in ethanol using a change in wavelength difference (∆λ) of 20 and 25 nm for the first and second combinations, respectively. Duloxetine and avanafil were estimated at 297.7 and 331 nm in their binary mixture, while duloxetine and tadalafil were determined at 290.3 and 297.7 nm, respectively. The linearity was achieved over the ranges of 0.1–1.5 μg mL−1 for both duloxetine and avanafil and 0.01–0.40 μg mL−1 for tadalafil, with limits of detection of 0.013, 0.022, and 0.004 μg mL−1 for duloxetine, avanafil, and tadalafil, respectively. Successful application of the developed approaches was accomplished for the estimation of the two mixtures in dosage forms as well as human plasma with excellent percentage recoveries (96–103.75% in plasma), which supports their suitability for use in quality control laboratories and pharmacokinetic studies. Moreover, the adopted approaches' greenness was evidenced by applying three tools.
- Open Access
- 27 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Factorial design-assisted reverse phase HPLC–UV approach for the concurrent estimation of cetirizine and azelastine in aqueous humor
A new analytical quality by design-assisted HPLC–UV approach is presented, for the first time, for the concurrent determination of cetirizine (CTZ) and azelastine (AZE) in raw materials, commercial eye drops and aqueous humor. The two drugs are co-administered as eye drops in severe ocular allergies. A 23 full factorial design was adopted for the chromatographic optimization to ensure the best analytical performance and reliability, as well as to save time, effort and solvent consumption. The parameters, including pH, acetonitrile ratio, and flow rate, were selected as independent factors. The responses analyzed were resolution and tailing of peaks. The separation was achieved through isocratic elution on C8 column with mobile phase made up of acetonitrile: 0.3% triethylamine of pH 5 (60:40 v/v) at a flow rate of 1.2 mL min−1 and detection at 216 nm. The elution time was less than 6 min. The approach was fully validated in accordance with International Council for Harmonization (ICH) guidelines. Good linearity was achieved over the concentration ranges of 1.0–30 and 0.5–10 µg mL−1 with limits of detection of 0.310 and 0.158 µg mL−1 and limits of quantification of 0.940 and 0.479 µg mL−1 for CTZ and AZE, respectively, with correlation coefficients of 0.9998. The intra- and inter-day precisions were lower than 2%. The good sensitivity of the approach permits the analysis of CTZ and AZE in spiked aqueous humor with mean percentage recoveries of 100.93 ± 1.42 and 100.11 ± 1.55, respectively. The statistical comparison between results of the developed method and the comparison method revealed no differences, indicating the accuracy of the method.
- 27 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Open AccessFactorial design-assisted reverse phase HPLC–UV approach for the concurrent estimation of cetirizine and azelastine in aqueous humor
A new analytical quality by design-assisted HPLC–UV approach is presented, for the first time, for the concurrent determination of cetirizine (CTZ) and azelastine (AZE) in raw materials, commercial eye drops and aqueous humor. The two drugs are co-administered as eye drops in severe ocular allergies. A 23 full factorial design was adopted for the chromatographic optimization to ensure the best analytical performance and reliability, as well as to save time, effort and solvent consumption. The parameters, including pH, acetonitrile ratio, and flow rate, were selected as independent factors. The responses analyzed were resolution and tailing of peaks. The separation was achieved through isocratic elution on C8 column with mobile phase made up of acetonitrile: 0.3% triethylamine of pH 5 (60:40 v/v) at a flow rate of 1.2 mL min−1 and detection at 216 nm. The elution time was less than 6 min. The approach was fully validated in accordance with International Council for Harmonization (ICH) guidelines. Good linearity was achieved over the concentration ranges of 1.0–30 and 0.5–10 µg mL−1 with limits of detection of 0.310 and 0.158 µg mL−1 and limits of quantification of 0.940 and 0.479 µg mL−1 for CTZ and AZE, respectively, with correlation coefficients of 0.9998. The intra- and inter-day precisions were lower than 2%. The good sensitivity of the approach permits the analysis of CTZ and AZE in spiked aqueous humor with mean percentage recoveries of 100.93 ± 1.42 and 100.11 ± 1.55, respectively. The statistical comparison between results of the developed method and the comparison method revealed no differences, indicating the accuracy of the method.
- 15 July 2022
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 61 (2) , 151-159
Green, Validated HPLC Method Coupled With Fluorescence Detection for the Analysis of Tafluprost in its Pure Form and Ophthalmic Formulation: Application to Aqueous Humor and Content Uniformity Testing
A green, simple and sensitive HPLC method coupled with fluorescence detection was implemented for the quantitative determination of the anti-glaucoma drug tafluprost (TFL). Liquid chromatography was performed on HyperClone™ ODS (C18) column of dimensions; 150 × 4.6 mm i.d. and 5 μm particle size using a green eluent; ethanol:0.01 M phosphate buffer (60:40 v/v, pH 4.5) delivered at 1 mL min−1. Fluorescence detection was accomplished at 220 nm (excitation) and 292 nm (emission). Bimatoprost (BIM) was used as an internal standard (I.S.). In this method, TFL was eluted after 6.70 minutes. The method satisfied International Council for Harmonization (ICH) validation guidelines, as proved by good linearity (r = 0.9999, over the range 0.05–2 μg mL−1), accuracy (recovery average 100.13 ± 1.27%), precision, robustness and specificity. The limit of detection and limit of quantification were found to be 0.016 and 0.048 μg mL−1, respectively. The proposed method has been successfully applied for the estimation of TFL in eye drops and aqueous humor. For the first time, the approach was applied with acceptable results for the evaluation of the uniformity of TFL eye drops content. Furthermore, Green Analytical Procedure Index (GAPI) and analytical Eco-scale were used to prove that the proposed HPLC method is environmentally friendly.
- 15 July 2022
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 61 (2) , 151-159
Green, Validated HPLC Method Coupled With Fluorescence Detection for the Analysis of Tafluprost in its Pure Form and Ophthalmic Formulation: Application to Aqueous Humor and Content Uniformity Testing
A green, simple and sensitive HPLC method coupled with fluorescence detection was implemented for the quantitative determination of the anti-glaucoma drug tafluprost (TFL). Liquid chromatography was performed on HyperClone™ ODS (C18) column of dimensions; 150 × 4.6 mm i.d. and 5 μm particle size using a green eluent; ethanol:0.01 M phosphate buffer (60:40 v/v, pH 4.5) delivered at 1 mL min−1. Fluorescence detection was accomplished at 220 nm (excitation) and 292 nm (emission). Bimatoprost (BIM) was used as an internal standard (I.S.). In this method, TFL was eluted after 6.70 minutes. The method satisfied International Council for Harmonization (ICH) validation guidelines, as proved by good linearity (r = 0.9999, over the range 0.05–2 μg mL−1), accuracy (recovery average 100.13 ± 1.27%), precision, robustness and specificity. The limit of detection and limit of quantification were found to be 0.016 and 0.048 μg mL−1, respectively. The proposed method has been successfully applied for the estimation of TFL in eye drops and aqueous humor. For the first time, the approach was applied with acceptable results for the evaluation of the uniformity of TFL eye drops content. Furthermore, Green Analytical Procedure Index (GAPI) and analytical Eco-scale were used to prove that the proposed HPLC method is environmentally friendly.